This HTML5 document contains 143 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n11http://dx.doi.org/10.4103/

Statements

Subject Item
wd:Q33668676
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel articol științific 2016 nî lūn-bûn tudományos cikk مقالة علمية artigo científico научна статия wissenschaftlicher Artikel artikull shkencor bài báo khoa học ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2016年论文 artigo científico (publicado na 2016) article scientifique (publié 2016) мақолаи илмӣ 2016年论文 2016年論文 artykuł naukowy 2016年论文 vědecký článek 2016年論文 artículo científico publicado en 2016 2016年の論文 article científic articolo scientifico научная статья wetenschappelijk artikel 2016年論文 2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված artículu científicu espublizáu en 2016 مقالهٔ علمی scientific article vitenskapelig artikkel vedecký článok bilimsel makale artikulong pang-agham article scientific 2016年论文 2016년 논문 מאמר מדעי наукова стаття, опублікована в грудні 2016 научни чланак mokslinis straipsnis 2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած 2016年论文 2016年論文 мақолаи илмӣ სამეცნიერო სტატია บทความทางวิทยาศาสตร์ vitskapeleg artikkel سائنسی مضمون scienca artikolo научни чланак naučni članak 2016年論文 teaduslik artikkel artigo científico (publicado na 2016) 2016年论文 επιστημονικό άρθρο videnskabelig artikel (udgivet 2016) tieteellinen artikkeli
p:P577
wds:Q33668676-B854AB12-E7A4-4E1A-B93A-59D2A5773299
wdt:P577
2017-05-01T00:00:00Z
p:P2860
wds:Q33668676-3572F9BF-EC4F-46E3-B9C0-6293707A0ABC wds:Q33668676-46454ED7-12A8-4667-9201-9B898728BFA9 wds:Q33668676-002B1021-B69A-4098-A40D-76C1318F0CB6 wds:Q33668676-0E6BFA77-5A0B-4291-83D5-9730C58FADF8 wds:Q33668676-117072B8-0628-40A2-8C9A-135AEA51ACB3 wds:Q33668676-CE047BAE-4F79-49EF-AD8C-B9C0E93935C6 wds:Q33668676-DA4C85D5-823D-41CF-867D-CD402A684EC6 wds:Q33668676-DB7BAC71-D015-4011-B511-ABAD1DBDA27B wds:Q33668676-E2BCFC59-60D8-4A2E-A28E-18C7417EFBE7 wds:Q33668676-E9E63A6F-0FBC-40C0-A241-509BA277B449 wds:Q33668676-84959E9F-3ED9-466B-899A-67A96DBEA3D5 wds:Q33668676-9212DC2F-D84D-4109-997F-F5FABC0B6D85 wds:Q33668676-9515A9DD-E15F-4B22-B564-482C433F53BF wds:Q33668676-9649E6B4-9508-4F79-BEAD-0A7BDA49DE41 wds:Q33668676-EEE2C300-CE9A-40F8-AD4E-C2D1B7D776BD wds:Q33668676-F09A72DB-C040-4EB9-980A-42A6E8F6AC93 wds:Q33668676-F71F251F-5457-4C12-A483-F721B595C293
wdt:P2860
wd:Q54501555 wd:Q39389586 wd:Q30396825 wd:Q44247995 wd:Q48905216 wd:Q39144187 wd:Q38111851 wd:Q38744524 wd:Q38000053 wd:Q47621362 wd:Q53131398 wd:Q35632475 wd:Q53023502 wd:Q28289877 wd:Q41319390 wd:Q39922053 wd:Q36010923
p:P2093
wds:Q33668676-FAA41D14-67A9-4FEE-8D29-AB844A31206E wds:Q33668676-E1518DB0-CEFE-41C1-B287-6DF9B0ED7CB8 wds:Q33668676-AB116154-D0CF-4A23-B24A-C2A957C344D3 wds:Q33668676-9CB10B64-A675-47B1-A652-DD416B06CCC1 wds:Q33668676-6D18FE8E-E39D-4321-BD95-D98545E4E3FA wds:Q33668676-30CF2243-37FC-483D-943A-801D92528743
wdt:P2093
Bo Dai Heng-Chuan Su Si-Long Hu Xiao-Ping Xu Guo-Wen Ling Ding-Wei Ye
rdfs:label
Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse
skos:prefLabel
Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse
schema:name
Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse
p:P50
wds:Q33668676-469DB9F0-305E-4BAF-B2BB-A6FBAE110884
wdt:P50
wd:Q80682572
p:P1476
wds:Q33668676-61A49507-7BF8-46B6-A00D-B025D3E20FAD
wdt:P1476
Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse
p:P304
wds:Q33668676-E0BA9B60-E4E3-4222-978D-61790A871273
wdt:P304
267-271
p:P31
wds:Q33668676-3AA448CE-AD66-4AA5-971E-AAB31D1269CA
wdt:P31
wd:Q13442814
p:P921
wds:Q33668676-1291EAFE-6694-440E-8D4A-06555F9C08F5
wdt:P921
wd:Q181257
p:P698
wds:Q33668676-D1E21092-1986-47E8-A873-667A0093EDE8
wdtn:P698
n10:27976632
wdt:P698
27976632
p:P1433
wds:Q33668676-351853F1-0718-48EF-A986-B7AC385F3E0D
wdt:P1433
wd:Q3220344
p:P433
wds:Q33668676-519ED7C7-77FA-458E-A99B-85D771E7CB01
p:P478
wds:Q33668676-58D5E0D9-7372-49A6-924A-4BA70F36C12D
wdt:P433
3
wdt:P478
19
p:P356
wds:Q33668676-8A799849-51F8-444B-8958-8D8BE88CBBAD
wdtn:P356
n11:1008-682X.192638
wdt:P356
10.4103/1008-682X.192638
p:P932
wds:Q33668676-0E18F005-F022-42A3-A6B6-964D5FDB94DC
wdt:P932
5427779